Uterine fibroids, resulting in muscle tissue, consisting mostly of women are the product of the uterus.
Resulting in uterine fibroids, consisting of the texture of the wall of the uterus, usually in diameter that can reach diameters ranging from 1-15 cm larger, usually the tumor that turns malignant, though rare, along with being a good-natured.
What is the incidence of fibroids?
These tumors are the most common tumors of female genital organs. uterine fibroids detected in one out of every four women over the age of 35. In general, fibroids can be single or multiple.
The causes of fibroids formation
Estrogen, known as the female hormone, causes the formation of myomas. Because of this, myomas usually grow up about 2-3 times during the reproductive age of women and during pregnancy. In women with menopause, myomas usually shrink if they do not use hormones.
Types of fibroids
Fibroids are divided into three groups according to their area in the uterine wall and the layers:
- Submucosal fibroids: consisting of the inner layer of the uterus and uterine fibroids enlarging the cavity to the least common but those which give rise to the most bleeding. Bleeding causes the prolongation of the number and the amount of bleeding.
- Intramural fibroids: uterine fibroids are the most common type and aryl oxime is formed in the middle layer of the muscles. This type of myoma leads to the prolongation of the menstrual period and the bleeding. Bleeding can cause anemia in the patient. Paralysis can lead to complaints such as abdominal pain and growing in the uterus, pressure on the bladder and frequent urination.
- Subserosal fibroids: fibroids are showing in the uterine growth of the outer layer and outwardly. They do not cause bleeding problems. But abdominal pain leads to complaints such as frequent urination and constipation.
Most of myomas do not cause any symptoms and do not require treatment. However, about 10-20% of all myomas show serious complaints. The most common complaint in myomas is the long and severe menstrual bleeding. These bleeds can sometimes be very, very coarse. Anemia may develop in patients due to chronic bleeding. Other symptoms are as follows:
- abdominal pain, feeling of fullness,
- back and leg pain,
- sexual intercourse pain,
- often urination,
In the case of myomas, if the myomas are growing, if the patient’s age is close to menapoa and the myomas are not complaining, then the treatment is not necessary. If there are complaints such as pain, frequent urination, increase in menstruation and anemia in patients, treatment is required.
In patients, growths can be seen in myomas with intermittent ultrasound or MR. In patient follow-ups, treatment will be necessary since initially the growing complaints will not lead to complaints but will lead to subsequent micturition.
The age of the patient is affected by the decision if a treatment decision is made. In younger patients, myomas are likely to lead to further growth and probing in the future, so in younger patients this should be considered important and treatment should be considered. Conversely, if the menopause is in close proximity to the patient, if the myomas are growing and not complaining, it may be appropriate for the patient not to be treated. When a treatment decision is made for myomas, all factors mentioned should be considered.
Treatment options in fibroid
Hormone therapy: Drugs called GNRH agonists are used that form menopausal and lower estrogen levels. In this way, reduction in myomas is achieved and patient complaints can be reduced. However, this improvement is not permanent. When hormone treatment is interrupted, the myomas grow rapidly and return to their original position in the veins. In addition, if these drugs are used for a long time, the patient causes osteoporosis (bone erosion) and severe symptoms of menopause. For this reason, hormone drugs should not be used for permanent treatment of myomas.
Myomectomy:It is the process of taking out the fetal myomas one at a time. This is intended to provide treatment of myomas without receiving the uterus, and fertility characteristics can be maintained especially in young women. Myomectomy is performed as an open surgical procedure, but it can be applied in laparoscopic and hysteroscopic surgical procedures in appropriate cases.
Myomectomy may be an appropriate treatment if there is only a small number of myomas in the uterine wall or a small number of superficial myomas in the result of MR examination. However, surgical intervention becomes more difficult in proportion to the number of myomas, risks increase, and operative results may not be satisfactory.
Hysterectomy:Under general anesthesia, removal of the entire uterus is a process. This procedure is performed in patients who have entered menopause in the case of a large number of myomas, or who no longer wish to have a pregnancy.
Hormone Spiral (Mirena):The hormone spiral is used for the illness of the patient in the absence of surgery, in health problems for which surgery is not appropriate, or for the correction of the anemia etc.
Mirena is a levonorgestrel, a kind of progesterone that is normally used in some birth control pills, which is normally released from the ovaries very slowly and in small amounts starting from the time it is worn. This hormone is effective only on the endometrium, that is, on the uterus, which prevents thickening of the thickened membrane. Thickening and bleeding due to this leads to the thinning of the intrauterine layer, which causes bleeding to decrease.
We are making this method particularly in patients close to menopause often. The main complaint of myomas is bleeding disorder and unrelated complaints. Patients entering menopause fibroids in patients with bleeding and menopause does mira until fully recovered from surgery until the patient will we prevent bleeding.
Your health is important to us. If you have any questions on these matters, Please contact Tugrul Abacioglu from the phone numbers below or our live support line and an appointment will be made.